Undisclosed TCR Program(s)
Solid Cancers
Pre-clinicalActive
Key Facts
About Captain T Cell
Captain T Cell is a private, pre-clinical stage biotech developing TCR-based cell therapies for solid tumors. Operating from Munich, Germany, the company is in the early stages of building its technology platform and pipeline. As a pre-revenue entity, its success will depend on advancing its research, securing partnerships and funding, and navigating the complex development pathway for cell therapies.
View full company profileTherapeutic Areas
Other Solid Cancers Drugs
| Drug | Company | Phase |
|---|---|---|
| TROCEPT-01 (ATTR-01) | Accession Therapeutics | Phase 1 |
| Two GATE™ (Undisclosed Targets) | Revitope Oncology | Preclinical |
| VicOryx | Oryx Translational Medicine | Phase 1/2 |
| MicOryx | Oryx Translational Medicine | Phase 1/2 |